Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
restructuring
Pharma
Inside Astellas CEO's plan to counter Xtandi's patent cliff
“It is not simply the cost optimization, but the way we do our business,” Astellas CEO Naoki Okamura explained to Fierce.
Angus Liu
Jun 11, 2026 6:00pm
Takeda's $1.3B savings drive to impact 4,500 roles in '26
May 13, 2026 11:41am
Novartis charts another 60 layoffs at US corporate outpost
May 4, 2026 11:09am
Large pharma companies reduced head counts by over 22K in 2025
Mar 23, 2026 4:25pm
Lonza shakes off capsule business in $3B deal with Lone Star
Mar 6, 2026 4:00pm
Takeda's neuroscience field force hit with layoffs
Jan 20, 2026 2:22pm
